Regional Fish Institute Ltd. in Japan is now accepting orders on a crowdfunding site for genetically manipulated farmed red sea bream that boasts 1.2 times thicker flesh than ordinary farmed ones.
Sales are initially restricted to 190 customers with deliveries expected to start in October. The production process is explained in detail with each purchase.
Kyoto University and Kindai University developed the fleshier fish variant by rendering a gene called myostatin that controls muscle growth.
The Regional Fish Institute, a biotech enterprise affiliated with Kyoto University, registered the commercialization of its “genome-edited food” with the government on Sept. 17.
On the same day, the health ministry declared that no safety examinations were required.
Genome editing, which aims to destroy or introduce particular genes, is also applied for increasing harvest yields in rice and other plant varieties.
As no foreign genes from other species were introduced into genome-processed items, as with genetic recombination, no safety checks were necessary.
This method is essentially the same as traditional selective breeding methods to create improved varieties.
The institute's sea bream is the first genome-edited animal product to be marketed in Japan.


Asian Markets Slide as New U.S. Strikes on Iran Spark Investor Caution
US Imposes Fresh Iran Oil Sanctions Despite Progress on Ceasefire Talks
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
Oil Prices Jump After New U.S. Strikes on Iran Raise Supply Concerns
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
New World Screwworm Found Near U.S. Border Raises Threat to Cattle Industry and Beef Prices
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Asian Currencies Steady as U.S.-Iran Ceasefire Extension Hopes Weigh on Dollar
Dow Hits Record High as Healthcare and Consumer Stocks Lead Wall Street Rally
China vs. NASA: The New Moon Race and What's at Stake by 2030
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Neuralink Expands Brain Implant Trials with 12 Global Patients
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 



